Introduction of site-specific mutations into the genome of influenza virus - PubMed (original) (raw)
Introduction of site-specific mutations into the genome of influenza virus
M Enami et al. Proc Natl Acad Sci U S A. 1990 May.
Abstract
We succeeded in rescuing infectious influenza virus by transfecting cells with RNAs derived from specific recombinant DNAs. RNA corresponding to the neuraminidase (NA) gene of influenza A/WSN/33 (WSN) virus was transcribed in vitro from plasmid DNA and, following the addition of purified influenza virus RNA polymerase complex, was transfected into MDBK cells. Superinfection with helper virus lacking the WSN NA gene resulted in the release of virus containing the WSN NA gene. We then introduced five point mutations into the WSN NA gene by cassette mutagenesis of the plasmid DNA. Sequence analysis of the rescued virus revealed that the genome contained all five mutations present in the mutated plasmid. The ability to create viruses with site-specific mutations will allow the engineering of influenza viruses with defined biological properties.
Similar articles
- Introduction of foreign sequences into the genome of influenza A virus.
García-Sastre A, Percy N, Barclay W, Palese P. García-Sastre A, et al. Dev Biol Stand. 1994;82:237-46. Dev Biol Stand. 1994. PMID: 7525392 - Transfection-mediated recombination of influenza A virus.
Bergmann M, García-Sastre A, Palese P. Bergmann M, et al. J Virol. 1992 Dec;66(12):7576-80. doi: 10.1128/JVI.66.12.7576-7580.1992. J Virol. 1992. PMID: 1279208 Free PMC article. - Amplification, expression, and packaging of foreign gene by influenza virus.
Luytjes W, Krystal M, Enami M, Parvin JD, Palese P. Luytjes W, et al. Cell. 1989 Dec 22;59(6):1107-13. doi: 10.1016/0092-8674(89)90766-6. Cell. 1989. PMID: 2598262 - Reverse genetics and influenza virus research.
Kiraly J, Kostolansky F. Kiraly J, et al. Acta Virol. 2009;53(4):217-24. doi: 10.4149/av_2009_04_217. Acta Virol. 2009. PMID: 19941384 Review. No abstract available.
Cited by
- High-efficiency formation of influenza virus transfectants.
Enami M, Palese P. Enami M, et al. J Virol. 1991 May;65(5):2711-3. doi: 10.1128/JVI.65.5.2711-2713.1991. J Virol. 1991. PMID: 2016777 Free PMC article. - Postexposure vaccination massively increases the prevalence of gamma-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice.
Belz GT, Stevenson PG, Castrucci MR, Altman JD, Doherty PC. Belz GT, et al. Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2725-30. doi: 10.1073/pnas.040575197. Proc Natl Acad Sci U S A. 2000. PMID: 10694575 Free PMC article. - Developing vaccines to combat pandemic influenza.
Robertson JS, Engelhardt OG. Robertson JS, et al. Viruses. 2010 Feb;2(2):532-546. doi: 10.3390/v2020532. Epub 2010 Feb 2. Viruses. 2010. PMID: 21994647 Free PMC article. - Expression of transgenes from newcastle disease virus with a segmented genome.
Gao Q, Park MS, Palese P. Gao Q, et al. J Virol. 2008 Mar;82(6):2692-8. doi: 10.1128/JVI.02341-07. Epub 2008 Jan 16. J Virol. 2008. PMID: 18199643 Free PMC article. - Positive strands to the rescue again: a segmented negative-strand RNA virus derived from cloned cDNAs.
Rose JK. Rose JK. Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):14998-5000. doi: 10.1073/pnas.93.26.14998. Proc Natl Acad Sci U S A. 1996. PMID: 8986751 Free PMC article. Review. No abstract available.
References
- J Virol. 1972 Oct;10(4):639-47 - PubMed
- Cell. 1977 Jan;10(1):1-10 - PubMed
- J Virol. 1977 Oct;24(1):170-6 - PubMed
- Science. 1980 Sep 19;209(4463):1392-6 - PubMed
- Cell. 1981 Jul;25(1):227-32 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources